Andrew Sloan, MD

Showing    of 9 results

UH Seidman Cancer Center Opens New Trial with PVSRIPO, a Viral-based Immunotherapy in Combination with Pembrolizumab for Patients with Recurrent GBM

The two therapies may be able to generate a potent and specific anti-tumor response in rGBM patients, given their different but complimentary mechanisms of action - Innovations in Cancer | Fall 2020

CETNO Advances Brain Tumor Translational Research from the Basic Science into Clinical Care

UH Research & Education Update | July 2020

Can the Polio Virus Kill Brain Tumors?

UH one of 4 sites participating in Phase II clinical trial - Innovations in Neurology & Neurosurgery | Winter 2020

UH Neurosurgeon Testing Novel Gene Therapy Treatment for Glioblastoma

New $2.7 million grant from the National Cancer Institute will help validate promising approach - Innovations in Cancer | Summer 2019

5-ALA: Giving Surgeons an Edge

5-ALA helps surgeons visualize boundaries of invading tumors for more complete removal - Innovations in Neurology & Neurosurgery - Winter 2019

Descriptive Data

Magnetic resonance fingerprinting technology developed in Cleveland shows promise in adult brain tumors - Innovations in Cancer | Spring 2017

Gene Therapy and Glioblastoma

Innovations in Cancer | Winter 2017

Proton Beam Therapy for Brain and Spine Tumors

Neurological Institute | January 2017

Results are loading...
Back to Top